Quince Therapeutics, Inc. (QNCX)
1.18
-0.04
(-3.28%)
USD |
NASDAQ |
May 14, 16:00
1.18
0.00 (0.00%)
After-Hours: 20:00
Quince Therapeutics EPS Diluted (Quarterly) : 3.908 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | -0.222 |
| BioXcel Therapeutics, Inc. | -1.028 |
| Gossamer Bio, Inc. | -0.2085 |
| Ernexa Therapeutics, Inc. | -6.952 |
| Acurx Pharmaceuticals, Inc. | -0.6184 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 35.91M |
| Total Expenses (Quarterly) | -35.91M |
| Enterprise Value | 1.478M |
| Earnings Yield | -771.4% |
| Normalized Earnings Yield | -698.22 |